FindTrial
Sign In

A study on drug therapy in heart failure patients.

Drug therapy optimization in hospitalized heart failure patients-a prospective observational study. - Heart Failure Medications

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/02/049719
Enrollment
101
Registered
2023-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I509- Heart failure, unspecified

Interventions

None listed

Sponsors

Anush V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patient either gender diagnosed and undergoing treatment for heart failure patients at least 3 months admitted for worsening of heart failure

Exclusion criteria

Exclusion criteria: Patients not willing to provide consent Patients diagnosed with heart failure at the time of admission

Design outcomes

Primary

MeasureTime frame
To study the pattern of heart failure medication therapy in hospitalized patientsTimepoint: 3 months—

Secondary

MeasureTime frame
to study the difference in drug therapy between preserved and reduced ejection fraction heart failureTimepoint: 3 months—

Countries

India

Contacts

Public ContactDr VikneswaranG

Narayana Institute of cardiac sciences

anushmichel1719@gmail.com7899612268

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026